Publications by authors named "Vanessa Coronel"
Background: Lecanemab and other new amyloid-targeting immunotherapies for Alzheimer's disease show great promise but, may also pose significant risk for patients. To facilitate the implementation and monitoring of lecanemab infusions at our tertiary medical center, we convened an interprofessional team. The team created a number of resources including patient handouts and medical documentation templates as well as systems and processes.
View Article and Find Full Text PDFArticle Synopsis
- Lecanemab, an amyloid-targeting immunotherapy for Alzheimer’s, shows promise but comes with potential risks for patients.
- An interprofessional team at a medical center developed resources like patient handouts and documentation templates to aid in the infusion process of lecanemab.
- The team plans to share these developed resources and processes with other healthcare settings to improve implementation and monitoring.